This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Ruth Heerdt and Pharmaceutical Inventions
Introduction
Ruth Heerdt was an inventor associated with Hoechst Aktiengesellschaft in Mannheim, Germany. Her patent work focused on sulfonyl-semicarbazide compounds and their potential use in lowering blood sugar levels.
Latest Patents
Heerdt is associated with 2 patents, including inventions concerning benzene sulfonyl ureas and hypoglycemically active benzenesulfonyl-semicarbazides. The latter patent describes compounds with variations in their chemical structures, including different substituents and ring systems, as well as their salts.
The patent presents these compounds as pharmaceutical preparations for oral administration and describes their use in lowering blood sugar levels in the treatment of diabetes mellitus. It also addresses a process for reducing blood sugar in people with diabetes.
Career Highlights
Heerdt’s recorded patent activity connects her to pharmaceutical research at Hoechst Aktiengesellschaft. The inventions attributed to her reflect efforts to develop medicinal compounds for diabetes treatment.
Collaborations
Rudi Weyer and Walter Aumuller are identified as Heerdt’s coworkers. Their names provide context for the professional environment surrounding her patent work, though the supplied information does not specify their roles in the inventions.
Conclusion
Ruth Heerdt’s patent record highlights pharmaceutical inventions involving benzenesulfonyl-semicarbazides and their proposed application in managing blood sugar levels in diabetes treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile